Inhibition of [3H]α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid [AMPA] binding by the anticonvulsant valproate in clinically relevant concentrations: An autoradiographic investigation in human hippocampus

Epilepsy Research

Volumn 31, Issue 2, 1998, Pages 153-157

  Kunig G ^a   Niedermeyer, B ^a   Deckert, J ^a   Gsell, W ^a   Ransmayr, G ^b   Riederer, P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

AMPA receptors; Human hippocampus; Valproate

Indexed keywords

AMPA RECEPTOR; ANTICONVULSIVE AGENT; GLUTAMATE RECEPTOR; TRITIUM; VALPROIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR STIMULATING AGENT;

ANTICONVULSANT THERAPY; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CONVULSION; DRUG RECEPTOR BINDING; EPILEPSY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; PRIORITY JOURNAL; SEIZURE; AGED; DRUG INTERACTION; METABOLISM;

AGED; AGED, 80 AND OVER; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANTICONVULSANTS; AUTORADIOGRAPHY; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; HUMANS; VALPROIC ACID;

EID: 0344474516     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00022-9     Document Type: Article

References (20)

1. Bowden C.L., Janicak P.G., Orsulak P., Swann A.C., Davis J.M., Calabrese J.R., Goodnick P., Small J.G., Rush A.J., Kimmel S.E., Risch S.C., Morris D.D. Relation of serum valproate concentration to response in mania. Am. J. Psychiatry. 153:1996;765-770.
2. Clarenbach, P., Fröscher, W., 1992. Antiepileptika, Neuropsychopharmaka. In: P. Riederer, G. Laux, W. Pöldinger (Eds.), Neurpsychopharmaka, Band 6. Springer Verlag, Wien, pp. 57-84.
3. Farooqui A., Horrocks L.A. Excitatory amino acid receptors, neuronal membrane phospholipid metabolism and neurological disorders. Brain Res. Rev. 16:1991;171-191.
4. Fredow G., Löscher W. Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant model of paroxysmal dystonia. Eur. J. Pharmacol. 192:1991;207-219.
5. Hosford D., Crain B., Cao Z., Bonhaus D., Friedman A., Okazaki M., Nadler V., McNamara J. Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA-receptor binding in epileptic human hippocampus. J. Neurosci. 11:1991;428-434.
6. Kelly K.M., Gross R.A., Macdonald R.L. Valproic acid selectively reduces the low-threshold (T) calcium in rat nodose neurons. Neurosci. Lett. 116:1990;233-238.
7. 3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid (AMPA) binding in human hippocampus. Neurosci. Lett. 169:1994;219-222.
8. Larsson O.M., Gram L., Schousboe A. Differential effects of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurons and astrocytes. Neuropharmacology. 25:1986;617-625.
9. Löscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem. Res. 18:1993;485-502.
10. Macdonald R.L., Kelly K.M. Antiepileptic drug mechanism of action. Epilepsia. 2(Suppl.):1995;2-12.
11. Maitre M., Ciesielski L., Cash C., Mandel P. Comparison of the structural characteristics of the 4-aminobutyrate: 2-oxoglutarate transaminases from rat and human brain, and of their affinities for certain inhibitors. Biochim. Biophys. Acta. 522:1978;385-399.
12. Meldrum, B.S., Garthwaite, J., 1991. Excitatory amino acid neurotoxicity and neurodegenerative disease. In: Lodge, D., Collingridge, G.L. (Eds.), The Pharmacology of Excitatory Amino Acids. A TIPS Special Report, pp. 54-61.
13. Meldrum B.S., Craggs M.D., Durmuller N., Smith S.E., Chapman A.G. The effects of AMPA receptor antagonists on kindled seizures and a reflex epilepsy in rodents and primates. Epilepsy Res. 9(Suppl.):1992;307-311.
14. Pranzatelli M., Nadi N.S. Mechanism of action of antiepileptic and antimyoclonic drugs. Adv. Neurol. 67:1995;329-360.
15. Richter A., Löscher W., Löschmann P.A. The AMPA receptor antagonist NBQX excerts antidystonic effects in an animal model of idiopathic dystonia. Eur. J. Pharmacol. 231:1993;287-291.
16. Steppuhn K.G., Turski L. Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. J. Pharmacol. Exp. Ther. 265:1993;1063-1070.
17. Turski L., Niemann W., Stephens D.N. Differential effects of antiepileptic drugs and β-carbolines on seizures induced by excitatory amino acids. Neuroscience. 39:1990;799-807.
18. Wilder, B.J., Rangel, R.J., 1989. Clinically relevant antiepileptic drug interactions. In: W.H. Pitlick (Ed.), Antiepileptic Drug Interactions. Raven Press, New York, pp. 65-75.
19. Wilinski S.I., Acosta G.B., Rubio M.C. Valproic acid differs in its in vitro effect on glutamic acid decarboxylase in neonatal and adult rat brain. Gen. Pharmacol. 27:1996;635-638.
20. Young D., Dragunow M. Non-NMDA glutamate receptors are involved in the maintenance of status epilepticus. Neuroreport. 5:1993;81-83.